Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

West Nile Virus: biology, transmission, and human infection.

Colpitts TM, Conway MJ, Montgomery RR, Fikrig E.

Clin Microbiol Rev. 2012 Oct;25(4):635-48. doi: 10.1128/CMR.00045-12. Review.

2.

Cell-intrinsic innate immune control of West Nile virus infection.

Diamond MS, Gale M Jr.

Trends Immunol. 2012 Oct;33(10):522-30. doi: 10.1016/j.it.2012.05.008. Epub 2012 Jun 20. Review.

3.

The outbreak of West Nile virus infection in the New York City area in 1999.

Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, Wong S, Layton M; 1999 West Nile Outbreak Response Working Group.

N Engl J Med. 2001 Jun 14;344(24):1807-14.

4.

West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins.

Xu Z, Waeckerlin R, Urbanowski MD, van Marle G, Hobman TC.

PLoS One. 2012;7(5):e37886. doi: 10.1371/journal.pone.0037886. Epub 2012 May 24.

5.

The long-term outcomes of human West Nile virus infection.

Sejvar JJ.

Clin Infect Dis. 2007 Jun 15;44(12):1617-24. Epub 2007 May 2. Review.

PMID:
17516407
6.

RNA interference screen for human genes associated with West Nile virus infection.

Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, Xavier RJ, Agaisse H, Fikrig E.

Nature. 2008 Sep 11;455(7210):242-5. doi: 10.1038/nature07207.

7.

Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Perwitasari O, Cho H, Diamond MS, Gale M Jr.

J Biol Chem. 2011 Dec 30;286(52):44412-23. doi: 10.1074/jbc.M111.285205. Epub 2011 Nov 7.

8.

A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection.

Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS.

PLoS Pathog. 2011 Dec;7(12):e1002407. doi: 10.1371/journal.ppat.1002407. Epub 2011 Dec 1.

9.

Neurologic manifestations and outcome of West Nile virus infection.

Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR.

JAMA. 2003 Jul 23;290(4):511-5. Erratum in: JAMA. 2003 Sep 10;290(10):1318.

PMID:
12876094
10.

[West Nile virus infection].

Pérez Ruiz M, Gámez SS, Clavero MA.

Enferm Infecc Microbiol Clin. 2011 Dec;29 Suppl 5:21-6. doi: 10.1016/S0213-005X(11)70040-4. Review. Spanish.

PMID:
22305666
11.

IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection.

Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, Gale M Jr.

PLoS Pathog. 2012;8(11):e1003039. doi: 10.1371/journal.ppat.1003039. Epub 2012 Nov 29.

12.

Controlling urban epidemics of West Nile virus infection.

Haley RW.

JAMA. 2012 Oct 3;308(13):1325-6. No abstract available.

PMID:
22922679
13.

Innate immune control of West Nile virus infection.

Arjona A, Wang P, Montgomery RR, Fikrig E.

Cell Microbiol. 2011 Nov;13(11):1648-58. doi: 10.1111/j.1462-5822.2011.01649.x. Epub 2011 Sep 22. Review.

14.

Host genetic risk factors for West Nile virus infection and disease progression.

Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M.

PLoS One. 2011;6(9):e24745. doi: 10.1371/journal.pone.0024745. Epub 2011 Sep 15.

15.

IPS-1 is essential for the control of West Nile virus infection and immunity.

Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja MK, Diamond MS, Gale M Jr.

PLoS Pathog. 2010 Feb 5;6(2):e1000757. doi: 10.1371/journal.ppat.1000757.

16.

West Nile virus infection and immunity.

Suthar MS, Diamond MS, Gale M Jr.

Nat Rev Microbiol. 2013 Feb;11(2):115-28. doi: 10.1038/nrmicro2950. Review.

PMID:
23321534
17.

Secreted Vago restricts West Nile virus infection in Culex mosquito cells by activating the Jak-STAT pathway.

Paradkar PN, Trinidad L, Voysey R, Duchemin JB, Walker PJ.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18915-20. doi: 10.1073/pnas.1205231109. Epub 2012 Oct 1.

18.

Immune responses to West Nile virus infection in the central nervous system.

Cho H, Diamond MS.

Viruses. 2012 Dec 17;4(12):3812-30. doi: 10.3390/v4123812. Review.

19.

Prognosis after West Nile virus infection.

Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, Drebot M, Neupane B, Fearon M, Mahony J.

Ann Intern Med. 2008 Aug 19;149(4):232-41.

PMID:
18711153
20.

Neurological manifestations of West Nile virus infection.

Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, Pepperell C, Jaigobin C.

Can J Neurol Sci. 2004 May;31(2):185-93.

PMID:
15198442

Supplemental Content

Support Center